Aim: Aim of this study was to evaluate prescription patterns of drugs for prophylaxis of secondary ischaemic events in patients surviving acute myocardial infarction (MI). Methodology: This cross–sectional, observational study was conducted at Department of Pharmacology, in association with Department of Cardiology, M. D. M. Hospital, a tertiary care teaching hospital attached to Dr. S.N. Medical College, Jodhpur, Rajasthan. Study population consisted of adult patients of both sex who had been treated for myocardial infarction and were discharged from hospital. Results: Out of 101 STEMI diagnosed patients, 66 were males and 35 were females. Maximum patients belonged to age group(60–69 yrs) . Antiplatelet and hypolipidemic drugs were prescribed to every patient. Atorvastatin was prescribed to 100% patients; while dual antiplatelet drugs (Aspirin and Clopidogrel ) used in 99% patients. Among antianginal drugs, Isosorbide dinitrate (ISDN) was most commonly prescribed drug in 66 patients (65.34%), followed by Nitroglycerin (NTG) in 62 patients (61.38%). While among antihypertensive drugs beta blockers (Metoprolol) was maximally prescribed , in 64 patients (63.36%), followed by ACE inhibitors (Ramipril) in 32 patients (31.68%), respectively. Patients were advised about lifestyle modifications like smoking cessation, avoidance of environmental tobacco smoke, physical activity for at least 30 minutes for seven days or minimum five days per week. Further, patients were advised to visit for first follow up after seven days. Conclusion: Findings of our study are in accordance with AHA and ESC 2018 guidelines.